| Estrogen receptor-α binds p53 tumor suppressor protein directly and represses its function W Liu, SD Konduri, S Bansal, BK Nayak, SA Rajasekaran, SM Karuppayil, ... Journal of Biological Chemistry 281 (15), 9837-9840, 2006 | 190 | 2006 |
| Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide GC Bobustuc, CH Baker, A Limaye, WD Jenkins, G Pearl, ... Neuro-oncology 12 (9), 917-927, 2010 | 178 | 2010 |
| Estrogen receptor α inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis A Sayeed, SD Konduri, W Liu, S Bansal, F Li, GM Das Cancer research 67 (16), 7746-7755, 2007 | 170 | 2007 |
| Inhibition of endothelial cell tube formation by the low molecular weight heparin, tinzaparin, is mediated by tissue factor pathway inhibitor SA Mousa, S Mohamed Thrombosis and haemostasis 92 (09), 627-633, 2004 | 152 | 2004 |
| Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation SD Konduri, R Medisetty, W Liu, BA Kaipparettu, P Srivastava, H Brauch, ... Proceedings of the National Academy of Sciences 107 (34), 15081-15086, 2010 | 134 | 2010 |
| Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas CN Rao, SS Lakka, Y Kin, SD Konduri, GN Fuller, S Mohanam, JS Rao Clinical cancer research 7 (3), 570-576, 2001 | 104 | 2001 |
| Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro. SD Konduri, A Tasiou, N Chandrasekar, JS Rao International journal of oncology 18 (1), 127-158, 2001 | 100 | 2001 |
| A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion SD Konduri, CN Rao, N Chandrasekar, A Tasiou, S Mohanam, Y Kin, ... Oncogene 20 (47), 6938-6945, 2001 | 96 | 2001 |
| Epidemiology of male breast cancer S Konduri, M Singh, G Bobustuc, R Rovin, A Kassam The Breast 54, 8-14, 2020 | 95 | 2020 |
| Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression S Konduri, J Colon, CH Baker, S Safe, JL Abbruzzese, A Abudayyeh, ... Molecular cancer therapeutics 8 (3), 533-542, 2009 | 82 | 2009 |
| Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice J Colon, MR Basha, R Madero-Visbal, S Konduri, CH Baker, LJ Herrera, ... Investigational new drugs 29, 41-51, 2011 | 78 | 2011 |
| Angiogenesis: an update and potential drug approaches M Abdelrahim, S Konduri, R Basha, PA Philip, CH Baker International journal of oncology 36 (1), 5-18, 2010 | 70 | 2010 |
| Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion SD Konduri, A Tasiou, N Chandrasekar, GL Nicolson, JS Rao Clinical & Experimental Metastasis 18, 303-308, 2000 | 62 | 2000 |
| In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2 SS Lakka, SD Konduri, S Mohanam, GL Nicolson, JS Rao Clinical & Experimental Metastasis 18, 239-244, 2000 | 62 | 2000 |
| Effects of radiation on the levels of MMP‐2, MMP‐9 and TIMP‐1 during morphogenic glial‐endothelial cell interactions C Nirmala, SL Jasti, R Sawaya, AP Kyritsis, SD Konduri, F Ali‐Osman, ... International journal of cancer 88 (5), 766-771, 2000 | 55 | 2000 |
| A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas A Tasiou, SD Konduri, N Yanamandra, DH Dinh, WC Olivero, M Gujrati, ... International journal of oncology 19 (3), 591-597, 2001 | 48 | 2001 |
| Triterpenoids from Glycine max decrease invasiveness and induce caspase-mediated cell death in human SNB19 glioma cells N Yanamandra, MA Berhow, S Konduri, DH Dinh, WC Olivero, ... Clinical & experimental metastasis 20, 375-383, 2003 | 47 | 2003 |
| Elevated levels of cathepsin B in human glioblastoma cell lines S Konduri, SS Lakka, A Tasiou, N Yanamandra, CS Gondi, DH Dinh, ... International journal of oncology 19 (3), 519-524, 2001 | 47 | 2001 |
| TP53 status as a determinant of pro-vs anti-tumorigenic effects of estrogen receptor-beta in breast cancer UK Mukhopadhyay, CC Oturkar, C Adams, N Wickramasekera, S Bansal, ... JNCI: Journal of the National Cancer Institute 111 (11), 1202-1215, 2019 | 44 | 2019 |
| Blockade of MGMT Expression by O6 Benzyl Guanine Leads to Inhibition of Pancreatic Cancer Growth and Induction of Apoptosis SD Konduri, J Ticku, GC Bobustuc, RM Sutphin, J Colon, B Isley, ... Clinical Cancer Research 15 (19), 6087-6095, 2009 | 40 | 2009 |
